Both Semaglutide and copyright are a group of medications called GLP-1 receptor agonists . These innovative substances function by imitating the body's inherent hormone , GLP-One , to help decrease sugar in the blood and promote a decrease in weight. This similar mechanism of function demonstrates why such therapies are commonly considered together